Molecular genetic analysis of a novel form of haemophilia a characterized by the variable expression of factor VIII
- 1 September 1990
- journal article
- research article
- Published by Elsevier in Thrombosis Research
- Vol. 59 (5) , 871-877
- https://doi.org/10.1016/0049-3848(90)90400-7
Abstract
No abstract availableThis publication has 10 references indexed in Scilit:
- Characterization of mutations in the factor VIII gene by direct sequencing of amplified genomic DNAGenomics, 1990
- DIRECT CARRIER TESTING IN 14 FAMILIES WITH HAEMOPHILIA BThe Lancet, 1989
- Two novel point mutations correlate with an altered developmental expression of blood coagulation factor IX (hemophilia B Leyden phenotype)Blood, 1989
- The putative factor IX gene promoter in hemophilia B LeydenBlood, 1988
- The Prophylactic Treatment of Hemophilia B Leyden with Anabolic SteroidsAnnals of Internal Medicine, 1985
- An estimate of unique DNA sequence heterozygosity in the human genomeHuman Genetics, 1985
- Characterization of the human factor VIII geneNature, 1984
- Danazol Increases Factor VIII and Factor IX in Classic Hemophilia and Christmas DiseaseNew England Journal of Medicine, 1983
- Hemophilia B LeydenNew England Journal of Medicine, 1982
- Oral contraception and the detection of carriers in haemophilia BThrombosis Research, 1978